Zdrowie i gospodarka · 15/02/2017
FDA Releases Revised Draft Guidance for Generic Difluprednate Emulsion
The FDA has made a revised draft guidance for industry available, providing specific recommendations for bioequivalence studies to support generic difluprednate emulsion applications